Source item

For $XFAB ER transcript: Just to recap, my idea on $XFAB foundry growth opportunities stemmed from SiC for 800v and photonixfab/MTP for CPO applicability. - $XFAB: "We are making progress in co-packaged optics". - "The transition to 800v... is expected to support demand for both SiC and GaN... for XFAB" So those analysts/people that were confidently bearposting about $XFAB that they had "0 exposure to 800V, photonics, CPO" just turned out plainly wrong. At the time I shared my idea, industry materials showed ASE and others cited photonixfab + XFAB as an upcoming CPO player in EU. And filings showed they had exposure names like $NVTS / $POWI in general. So glad $XFAB went out to explicitly clear things up to state they were developing in CPO/800v. Okay back to the ER: - "We continue to expect photonics volume production to start in 2028". Company currently has three silicon photonics projects in development with key partners. I thought it would ramp sometime in H2 2027, but was probably early by a few months. - Several new data center design wins, eg. 3 new SiC design wins (consistent with general 2027 ramp as 800v deployment takes off). So once those ramp in 2027-2028, (markets tend to price things ahead of time), I'd expect $XFAB to be rerated based on growth opportunities. TLDR: - Current revenue numbers not as impressive. - $XFAB confirmed direct exposure to CPO and 800V shifts (biggest win for thesis) - 800V exposure opportunities for SiC (should be 2027) - Timeline is 2028 ramp for photonics volume production Happy exposure thesis to CPO/800V was confirmed from this ER. Might be a bit of waiting for revenue ramp.